Adenovirus E1A, not human papillomavirus E7, sensitizes tumor cells to lysis by macrophages through nitric oxide-and TNF-α-dependent mechanisms despite up-regulation of 70-kDa heat shock protein

Journal of Immunology

Volumn 170, Issue 8, 2003, Pages 4119-4126

  Miura, Tanya A ^a,b   Morris, Kristin ^a,b   Ryan, Sharon ^a   Cook, James L ^c   Routes, John M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; HEAT SHOCK PROTEIN 70; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL KILLING; CELL PROTECTION; CYTOLYSIS; E1A GENE; E7 GENE; EFFECTOR CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SEROTYPE; TUMOR CELL; VIRUS EXPRESSION; VIRUS GENE; WART VIRUS;

EID: 0037446784     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.8.4119     Document Type: Article

References (77)

1. Munger, K., J. R. Basile, S. Duensing, A. Eichten, S. L. Gonzalez, M. Grace, and V. L. Zacny. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888.
2. Bayley, S. T., and J. S. Mymryk. 1994. Adenovirus EIA proteins and transformation. Int. J. Oncol. 5:425.
3. Gallimore, P. H., and A. S. Turnell. 2001. Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20:7824.
4. Graham, F. L. 1984. Transformation by and oncogenicity of human adenoviruses. In The Adenoviruses. H. S. Ginsberg, ed. Plenum, New York, p. 339.
5. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Sremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111.
6. Smotkin, D., and F. O. Wettstein. 1986. Transcription of human papillomavirus type 16 early genes in cervical cancer and a cervical cancer derived cell line and identification of the E7 protein. Proc. Natl. Acad. Sci. USA 83:4680.
7. Halbert, C., G. Demers, and D. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473.
8. Banks, L., F. Moreau, K. Vousden, D. Pim, and G. Matlashewski. 1991. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages. J. Immunol. 146:2037.
9. van den Elsen, P. J., A. Houweling, and A. J. van der Eb. 1983. Morphological transformation of human adenoviruses is determined to large extent by gene production of region E1A. Virology 131:242.
10. Brokaw, J. L., C. L. Yee, and K. Münger. 1994. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Virology 205:603.
11. Scheffner, M., B. Werness, J. Huibregtse, A. Levine, and P. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129.
12. Werness, B., A. Levine, and P. Howley. 1990. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76.
13. Zantema, A., P. I. Schrier, A. Davis-Oliver, T. van Laar, R. T. Vaessen, and A. J. van der Eb. 1985. Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen 53 in transformed cells. Mol. Cell. Biol. 5:3084.
14. Bosch, F. X., M. M. Manos, N. Muñoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796.
15. Green, M., W. Wold, J. Mackey, and P. Rigden. 1979. Analysis of human tonsil and cancer DNAs and RNAs for DNA sequences of group C (serotypes 1, 2, 5 and 6) human adenovirus. Proc. Natl. Acad. Sci. USA 76:6606.
16. Raska, K., Jr., and P. H. Gallimore. 1982. An inverse relation of the oncogenic potential of adenovirus-transformed cells and their sensitivity to killing by syngeneic natural killer cells. Virology 123:8.
17. Bernards, R., P. I. Schrier, A. Houweling, J. L. Bos, and A. J. van der Eb. 1983. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature 305:776.
18. Schrier, P. I., R. Bernards, R. T. Vaessen, A. Houweling, and A. J. van der Eb. 1983. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed cells. Nature 305:771.
19. Lewis, A., Jr., and J. Cook. 1982. Spectrum of tumorigenic phenotypes among adenovirus 2-, adenovirus 12-, and simian virus 40-transformed syrian hamster cells defined by host cellular immune-tumor cell interactions. Cancer Res. 42:939.
20. Routes, J. M., and S. Ryan. 1995. Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. J. Virol. 69:7639.
21. Routes, J. M., S. Ryan, J. Steinke, and J. L. Cook. 2000. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development. Virology 277:48.
22. Cook, J. L., T. A. Walker, A. M. Lewis, Jr., H. E. Ruley, F. L. Graham, and S. H. Pilder. 1986. Expression of the adenovims E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Proc. Natl. Acad. Sci. USA 83:6965.
23. Denis, M., K. Chadee, and G. J. Matlashewski. 1989. Macrophage killing of human papillomavirus type 16-transformed cells. Virology 170:342.
24. MackiMicking, J., Q. W. Xie. and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
25. Duerksen-Hughes, P., W. S. M. Wold, and L. R. Gooding. 1989. Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J. Immunol. 143:4193.
26. Chen, M.-J., C. Q. Earl, B. Holskin, M. Anzano, D. Shalloway, and J. L. Cook. 1988. Studies on the NIH 3T3 cells sensitized to tumor necrosis factor by the expression of adenovirus E1A oncogene. In Monokines and Other Non-Lymphocyte Cytokines. N. C. Powanda, ed. Liss, New York, p. 243.
27. Cook, J. L., D. L. May, B. A. Wilson, B. Holskin, M. J. Chen, D. Shalloway, and T. A. Walker. 1989. Role of tumor necrosis factor-α in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages. J. Immunol. 142:4527.
28. Thompson, D. A., V. Zacny, G. S. Belinsky, M. Classon, D. L. Jones, R. Schlegel, and K. Munger. 2001. The HPV E7 oncoprotein inhibits tumor necrosis factor-α-mediated apoptosis in normal human fibroblasts. Oncogene 20:3629.
29. Duerksen-Hughes, P. J., D. B. Day, S. M. Laster, N. A. Zachariades, L. Aquino, and L. R. Gooding. 1992. Both tumor necrosis factor and nitric oxide participate in lysis of simian virus 40-transformed cells by activated macrophages. J. Immunol. 149:2114.
30. Cook, J. L., B. A. Routes, C. Y. Leu, T. A. Walker, and K. L. Colvin. 1999. E1A oncogene-induced cellular sensitization to immune-mediated apoptosis is independent of p53 and resistant to blockade by E1B 19 kDa protein. Exp. Cell Res. 252:199.
31. Cook, J. L., T. A. Potter, D. Bellgrau, and B. A. Routes. 1996. E1A oncogene expression in target cells induces cytolytic susceptibility at a post-recognition stage in the interaction with killer lymphocytes. Oncogene 12:833.
32. Imperiale, M. J., H.-T. Kao, L. T. Feldman, J. R. Nevins, and S. Strickland. 1984. Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity. Mol. Cell. Biol. 4:867.
33. Nevins, J. R. 1982. Induction of the synthesis of a 70,000 dalton mammalian heat shock protein by the adenovirus E1A gene product. Cell 29:913.
34. Simon, M. C., K. Kitchener, H.-T. Kao, E. Hickey, L. Weber, R. Voellmy, N. Heintz, and J. R. Nevins. 1987. Selective induction of human heat shock gene transcription by the adenovirus E1A gene products, including the 12S E1A product. Mol. Cell. Biol. 7:2884.
35. Klein, S. D., and B. Brune. 2002. Heat-shock protein 70 attenuates nitric oxideinduced apoptosis in RAW macrophages by preventing cytochrome c release. Biochem. J. 362:635.
36. Gurbuxani, S., J. M. Bruey, A. Fromentin, N. Larmonier, A. Parcellier, M. Jaattela, F. Martin, E. Solary, and C. Garrido. 2001. Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene 20:7478.
37. Burkart, V., H. Liu, K. Bellmann, D. Wissing, M. Jaattela, M. G. Cavallo, P. Pozzilli, K. Briviba, and H. Kolb. 2000. Natural resistance of human β cells toward nitric oxide is mediated by heat shock protein 70. J. Biol. Chem. 275:19521.
38. Melcher, A., S. Todryk, N. Hardwick, M. Ford, M. Jacobson, and R. G. Vile. 1998. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4:581.
39. White, E., D. Spector, and W. Welch. 1988. Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells. J. Virol. 62:4153.
40. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNF-α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.
41. Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
42. Chartrain, N. A., D. A. Geller, P. P. Koty, N. F. Sitrin, A. K. Nussler, E. P. Hoffman, T. R. Billiar, N. I. Hutchinson, and J. S. Mudgett. 1994. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J. Biol. Chem. 269:6765.
43. Pollock, J. D., D. A. Williams, M. A. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202.
44. Mule, J. J., J. C. Yang, R. L. Afreniere, S. Shu, and S. A. Rosenberg. 1987. Identification of cellular mechanisms operational in vivo during regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin-2. J. Immunol. 139:285.
45. Frisch, S. M., R. Reich, I. E. Collier, L. T. Genrich, G. T. Martin, and G. Goldberg. 1990. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene 5:75.
46. Cook, J. L., D. L. May, A. M. Lewis, Jr., and T. A. Walker. 1987. Adenovirus EIA gene induction of susceptibility to lysis by natural killer cells and activated macrophages in infected rodent cells. J. Virol. 61:3510.
47. Hibbs, J. B., Jr. 1976. The Macrophage as a Tumoricidal Effector Cell: A Review of In Vivo and In Vitro Studies on the Mechanism of the Activated Macrophage Nonspecific Cytotoxic Reaction. Academic, New York.
48. Erwig, L. P., D. C. Kluth, G. M. Walsh, and A. J. Rees. 1998. Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J. Immunol. 161:1983.
49. Higuchi, M., N. Higashi, H. Taki, and T. Osawa. 1990. Cytolytic mechanisms of activated macrophages: tumor necrosis factor and L-arginine-dependent mechanisms act synergistically as the major cytolytic mechanisms of activated macrophages. J. Immunol. 144:1425.
50. Keller, R., R. Keist, A. Wechsler, T. P. Leist, and P. H. van der Meide. 1990. Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor. Int. J. Cancer 46:682.
51. Fehsel, K., K. D. Kroncke, K. L. Meyer, H. Huber, V. Wahn, and V. Kolb-Bachofen. 1995. Nitric oxide induces apoptosis in mouse thymocytes. J. Immunol. 155:2858.
52. Bellmann, K., M. Jaattela, D. Wissing, V. Burkart, and H. Kolb. 1996. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett. 391:185.
53. Jaattela, M., D. Wissing, P. Bauer, and G. Li. 1992. Major heat shock protein hsp70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J. 11:3507.
54. Granger, D., R. Taintor, J. Cook, and J. Hibbs, Jr. 1980. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J. Clin. Invest. 65:357.
55. Cook, J. L., J. B. J. Hibbs, and A. M. J. Lewis. 1980. Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species specific viral oncogenicity. Proc. Natl. Acad. Sci. USA 77:6773.
56. Basile, J. R., V. Zacny, and K. Munger. 2001. The cytokines tumor necrosis factor-α (TNF-α) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J. Biol. Chem. 276:22522.
57. Stoppler, H., M. C. Stoppler, E. Johnson, C. M. Simbulan-Rosenthal, M. E. Smulson, S. Iyer, D. S. Rosenthal, and R. Schlegel. 1998. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene 17:1207.
58. Garrido, C., S. Gurbuxani, L. Ravagnan, and G. Kroemer. 2001. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochim. Biophys. Acta 286:433.
59. Jolly, C., and R. I. Morimoto. 2000. Role of the heat shock response and molecular chaperones in oncogenesis and cell death, J. Natl. Cancer Inst. 92:1564.
60. Ravagnan, L., S. Gurbuxani, S. A. Susin, C. Maisse, E. Daugas, N. Zamzami, T. Mak, M. Jaattela, J. M. Penninger, C. Garrido, and G. Kroemer. 2001. Heatshock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3:839.
61. Multhoff, G., C. Botzler, L. Jennen, J. Schmidt, J. Ellwart, and R. Issels. 1997. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J. Immunol. 158:4341.
62. Srivastava, P. K. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 2002:395.
63. Panjwani, N. N., L. Popova, and P. K. Srivastava. 2002. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168:2997.
64. Todryk, S., A. A. Melcher, N. Hardwick, E. Linardakis, A. Bateman, M. P. Colombo, A. Stoppacciaro, and R. G. Vile. 1999. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163:1398.
65. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303.
66. Binder, R. J., N. E. Blachere, and P. K. Srivastava. 2001. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules. J. Biol. Chem. 276:17163.
67. Bellgrau, D., T. A. Walker, and J. L. Cook. 1988. Recognition of adenovirus E1A gene products on immortalized cell surfaces by cytotoxic T lymphocytes. J. Virol. 62:1513.
68. Routes, J., D. Bellgrau, W. McGrory, D. Bautista, F. Graham, and J. Cook. 1991. Anti-adenovirus type 5 cytotoxic T lymphocytes: immunodominant epitopes are encoded by the E1A gene. J. Virol. 65:1450.
69. k mice. J. Immunol. 146:3977.
70. Gough, M. J., A. A. Melcher, A. Ahmed, M. R. Crittenden, D. S. Riddle, E. Linardakis, A. N. Ruchatz, L. M. Emiliusen, and R. G. Vile. 2001. Macrophages orchestrate the immune response to tumor cell death. Cancer Res. 61:7240.
71. Walker, T. A., B. A. Wilson, A. M. Lewis, Jr., and J. L. Cook. 1991. E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity. Proc. Natl. Acad. Sci. USA 88:6491.
72. Frisch, S. M. 1991. Antioncogenic effect of adenovirus E1A in human tumor cells. Proc. Natl. Acad. Sci. USA 88:9077.
73. Chang, J. Y., W. Xia, R. Shao, F. Sorgi, G. N. Hortobagyi, L. Huang, and M.-C. Hung. 1997. The tumor suppression activity of El A in HER-2/neu-overexpressing breast cancer. Oncogene 14:561.
74. Borysiewicz, L. K., A. Fiander, M. Nimako, G. W. G. Wilkinson, D. Westmoreland, A. S. Evans, M. Adams, S. N. Stacey, M. E. G. Boursnell, E. Rutherford, et al. 1996. A recombinant vaccinia virus encoding human papillomavirus type 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 347:1523.
75. Evans, C. S., T. Bauer, T. Grubert, C. Brucker, S. Baur, K. Heeg, H. Wagner, and G. B. Lipford. 1996. HLA-2-restricted peripheral blood cytolytic lymphocyte response to HPV type 16 proteins from E6 and E7 from patients with neoplastic cervical lesions. Cancer Immunol. Immunother. 42:151.
76. Ressing, M. E., W. J. van Driel, E. Celis, A. Sette, R. M. Brandt, J. D. Hartman, J. D. H. Anholts, G. M. Schreuder, W. B. ter Harmsel, B. J. Fleuren, et al. 1996. Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope. Cancer Res. 56:582.
77. Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A. Ledbetter, P. McGowan, and P. S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093. K. E.